196 related articles for article (PubMed ID: 21107304)
1. Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.
Jacobson PA; Schladt D; Oetting WS; Leduc R; Guan W; Matas AJ; Lamba V; Mannon RB; Julian BA; Israni A;
Transplantation; 2011 Feb; 91(3):309-16. PubMed ID: 21107304
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8.
Bouamar R; Elens L; Shuker N; van Schaik RH; Weimar W; Hesselink DA; van Gelder T
Transplantation; 2012 May; 93(10):e39-40; author reply e41-2. PubMed ID: 22572835
[No Abstract] [Full Text] [Related]
3. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
Kuypers DR; de Jonge H; Naesens M; de Loor H; Halewijck E; Dekens M; Vanrenterghem Y
Clin Ther; 2008 Apr; 30(4):673-83. PubMed ID: 18498916
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.
Varnell CD; Fukuda T; Kirby CL; Martin LJ; Warshaw BL; Patel HP; Chand DH; Barletta GM; Van Why SK; VanDeVoorde RG; Weaver DJ; Wilson A; Verghese PS; Vinks AA; Greenbaum LA; Goebel J; Hooper DK
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28869324
[TBL] [Abstract][Full Text] [Related]
5. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.
Shin BC; Chung JH; Kim HL
Transplant Proc; 2013 Oct; 45(8):2968-9. PubMed ID: 24157014
[TBL] [Abstract][Full Text] [Related]
7. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
Oreschak K; Saba LM; Rafaels N; Ambardekar AV; Deininger KM; PageII R; Lindenfeld J; Aquilante CL
J Heart Lung Transplant; 2021 Sep; 40(9):917-925. PubMed ID: 34253456
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.
Oetting WS; Wu B; Schladt DP; Guan W; van Setten J; Keating BJ; Iklé D; Remmel RP; Dorr CR; Mannon RB; Matas AJ; Israni AK; Jacobson PA;
Transplantation; 2019 Jun; 103(6):1131-1139. PubMed ID: 30801552
[TBL] [Abstract][Full Text] [Related]
9. Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.
Woillard JB; Picard N; Thierry A; Touchard G; Marquet P;
Pharmacogenet Genomics; 2014 May; 24(5):256-62. PubMed ID: 24681964
[TBL] [Abstract][Full Text] [Related]
10. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
[TBL] [Abstract][Full Text] [Related]
11. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Rerolle JP; Szelag JC; Le Meur Y
Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
[No Abstract] [Full Text] [Related]
12. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.
Brum S; Nolasco F; Sousa J; Ferreira A; Possante M; Pinto JR; Barroso E; Santos JR
Transplant Proc; 2008 Apr; 40(3):752-4. PubMed ID: 18455007
[TBL] [Abstract][Full Text] [Related]
13. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.
Vanhove T; Kuypers D; Claes KJ; Evenepoel P; Meijers B; Naesens M; Vanrenterghem Y; Cornelis T; Bammens B
Transpl Int; 2013 Aug; 26(8):813-21. PubMed ID: 23746202
[TBL] [Abstract][Full Text] [Related]
14. [Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir].
Izquierdo MJ; Rodrigo E; de Cos MA; Arias M
Nefrologia; 2007; 27(2):232-3. PubMed ID: 17564576
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Basara N; Blau WI; Römer E; Rudolphi M; Bischoff M; Kirsten D; Sanchez H; Günzelmann S; Fauser AA
Bone Marrow Transplant; 1998 Jul; 22(1):61-5. PubMed ID: 9678797
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
17. Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients.
Sobiak J; Kamińska J; Głyda M; Duda G; Chrzanowska M
Clin Transplant; 2013; 27(4):E407-14. PubMed ID: 23758434
[TBL] [Abstract][Full Text] [Related]
18. Management of leukopenia in kidney and pancreas transplant recipients.
Hartmann EL; Gatesman M; Roskopf-Somerville J; Stratta R; Farney A; Sundberg A
Clin Transplant; 2008; 22(6):822-8. PubMed ID: 19040562
[TBL] [Abstract][Full Text] [Related]
19. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.
Silverstein DM; Aviles DH; LeBlanc PM; Jung FF; Vehaskari VM
Pediatr Transplant; 2005 Oct; 9(5):589-97. PubMed ID: 16176415
[TBL] [Abstract][Full Text] [Related]
20. Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.
Molina Perez E; Fernández Castroagudín J; Seijo Ríos S; Mera Calviño J; Tomé Martínez de Rituerto S; Otero Antón E; Bustamante Montalvo M; Varo Perez E
Transplant Proc; 2009 Apr; 41(3):1047-9. PubMed ID: 19376423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
